Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Anebulo Pharmaceuticals Inc

ANEB
2,63
-0,20 (-7,07%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:07:13
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:05EDGAR2Form 8-K - Current report
15/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:15EDGAR2Form 8-K - Current report
15/5/202419:05BWAnebulo Pharmaceuticals Reports Third Quarter Fiscal Year..
13/2/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202422:15EDGAR2Form 8-K - Current report
13/2/202422:05BWAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year..
21/11/202322:01EDGAR2Form 8-K - Current report
14/11/202322:05BWAnebulo Pharmaceuticals Reports First Quarter Fiscal Year..
30/10/202314:31EDGAR2Form ARS - Annual Report to Security Holders
30/10/202314:22EDGAR2Form DEF 14A - Other definitive proxy statements
19/10/202323:18EDGAR2Form PRE 14A - Other preliminary proxy statements
06/10/202322:10EDGAR2Form 8-K - Current report
06/10/202322:06BWAnebulo Pharmaceuticals Announces New CEO
02/10/202323:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/9/202322:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/9/202322:29BWAnebulo Pharmaceuticals Reports Fourth Quarter and Fiscal..
20/9/202322:15EDGAR2Form 8-K - Current report
05/9/202314:00EDGAR2Form 8-K - Current report
30/8/202314:00BWAnebulo Pharmaceuticals to Present at Upcoming Investor and..
21/8/202314:00BWAnebulo Receives Positive Feedback from FDA on Path to..
Apertura: 2,75 Min: 2,7497 Max: 2,75
Chiusura: 2,83

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network